Cargando…
POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY
Autores principales: | AHMAD, S., Bhasin, N., Sinha, S., Sayed, S.A., Bansode, J., Swami, R., Mehta, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049664/ http://dx.doi.org/10.1016/j.ekir.2021.03.494 |
Ejemplares similares
-
POS-865 RENAL RECOVERY AFTER ACUTE KIDNEY INJURY ASSOCIATED TO COVID REQUIRING CONTINUOUS RENAL REPLACEMENT THERAPY DURING ICU HOSPITALIZATION
por: Pérez Hettinga, M.A., et al.
Publicado: (2022) -
Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients
por: Li, Lung-Chih, et al.
Publicado: (2017) -
Machine learning model to predict hypotension after starting continuous renal replacement therapy
por: Kang, Min Woo, et al.
Publicado: (2021) -
Clinical Profile and Outcome of Hemodialysis Patients with SARS COV2 Infection in a Tertiary Care Centre in Mumbai, India
por: Sinha, Smriti, et al.
Publicado: (2021) -
Acute Kidney Injury in COVID-19: Clinical Profile and Outcome
por: Bansode, Jyoti, et al.
Publicado: (2022)